Adipokines and systemic lupus erythematosus: relationship with metabolic syndrome and cardiovascular disease risk factors

scientific article published on 01 February 2009

Adipokines and systemic lupus erythematosus: relationship with metabolic syndrome and cardiovascular disease risk factors is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3899/JRHEUM.080503
P698PubMed publication ID19132788

P50authorDomenico Paolo Emanuele MargiottaQ41346492
Fabio CacciapagliaQ56251710
Antonella Maria Vittoria AfeltraQ67891878
Marta VadaccaQ93381135
P2093author name stringAntonio Amoroso
Amelia Rigon
Giusy Coppolino
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectsystemic lupus erythematosusQ1485
cardiovascular diseaseQ389735
metabolic syndromeQ657193
P304page(s)295-297
P577publication date2009-02-01
P1433published inThe Journal of RheumatologyQ7743623
P1476titleAdipokines and systemic lupus erythematosus: relationship with metabolic syndrome and cardiovascular disease risk factors
P478volume36

Reverse relations

cites work (P2860)
Q26865268Adipokines, metabolic syndrome and rheumatic diseases
Q38105930Association between leptin and systemic lupus erythematosus
Q40315110Association of leptin and leptin receptor gene polymorphisms with systemic lupus erythematosus in a Chinese population.
Q26864855Beyond fat mass: exploring the role of adipokines in rheumatic diseases
Q34081242Cardiovascular involvement in autoimmune diseases
Q36798494Daily cytokine fluctuations, driven by leptin, are associated with fatigue severity in chronic fatigue syndrome: evidence of inflammatory pathology
Q34475777Elevated adiponectin serum levels in women with systemic autoimmune diseases
Q30249547Emerging role of adipokines in systemic lupus erythematosus
Q35131524Fish oil N-3 fatty acids increase adiponectin and decrease leptin levels in patients with systemic lupus erythematosus
Q33577477Leptin in immuno-rheumatological diseases
Q45162401Leptin, adiponectin and vascular stiffness parameters in women with systemic lupus erythematosus
Q33730536Management of cardiovascular complications in systemic lupus erythematosus
Q47179163Metabolic syndrome in Iranian patients with systemic lupus erythematosus and its determinants
Q37335690Metabolic syndrome in lupus patients in northeast of Iran, and their lifestyle habits
Q36419531Modulation of Lupus Phenotype by Adiponectin Deficiency in Autoimmune Mouse Models
Q64120434Physical Fitness and Body Composition in Women with Systemic Lupus Erythematosus
Q53441382Physical activity and sedentary behavior in patients with Systemic Lupus Erythematosus.
Q41608422Prevalence of metabolic syndrome in a cohort of systemic lupus erythematosus patients from Northeastern Brazil: association with disease activity, nephritis, smoking, and age.
Q35174611Pro-inflammatory high-density lipoproteins and atherosclerosis are induced in lupus-prone mice by a high-fat diet and leptin
Q44209888Resistin as a potential marker of renal disease in lupus nephritis
Q47148225Resistin levels in lupus and associations with disease-specific measures, insulin resistance, and coronary calcification
Q27008359Role of adipokines in atherosclerosis: interferences with cardiovascular complications in rheumatic diseases
Q47565308Serum adipokine levels and associations with patient-reported fatigue in systemic lupus erythematosus
Q41230561Serum levels of adiponectin and leptin as biomarkers of proteinuria in lupus nephritis
Q47118363The relation between, metabolic syndrome and quality of life in patients with Systemic Lupus Erythematosus
Q36095970The role of adipokines in connective tissue diseases.
Q91993138Visfatin and chemerin levels correspond with inflammation and might reflect the bridge between metabolism, inflammation and fibrosis in patients with systemic sclerosis
Q82928639Visfatin levels and intima-media thicknesses in rheumatic diseases
Q38591752Why are kids with lupus at an increased risk of cardiovascular disease?

Search more.